Tatton Consulting supported London-based rare disease diagnostics company Mendelian in its successful application to Innovate UK Smart Grants, awarded £325,912 by Innovate UK for the project Expansion of the Mendelian Disease Scanner.
About the funded R&D project
Expanding the Rare Disease Scanner beyond its initial disease set. Each additional condition requires its own phenotype logic validated against real records, so coverage expansion is a research problem rather than a configuration exercise.
Award details
- Grant awarded: £325,912
- Competition: Innovate UK Smart Grants
- Competition year: 2021/22
- Project: Expansion of the Mendelian Disease Scanner
- Sector: Rare disease / clinical software
- Independent verification: Innovate UK funded projects transparency dataset (UKRI), published 10 August 2026
See all the awards Tatton Consulting has supported on our grant successes page.
